Le Lézard
Classified in: Health
Subjects: MAV, CFG

Media Advisory - Prime Minister's itinerary for Thursday, March 7, 2024


OTTAWA, ON, March 6, 2024 /CNW/ -

Note: All times local

Greater Toronto Area, Ontario



11:15 a.m.

The Prime Minister will meet with nurses and physicians.




Note for media:

  • Pooled photo opportunity


11:30 a.m.

The Prime Minister will make a pharmacare announcement. The Deputy Prime Minister
and Minister of Finance, Chrystia Freeland, and the Minister for Women and Gender
Equality and Youth, Marci Ien, will also be in attendance. A media availability will follow.




Notes for media: 

  • Open coverage
  • Media are asked to arrive no later than 10:30 a.m.
  • Media interested in participating can contact [email protected] for details.


3:30 p.m.

The Prime Minister will meet with health care professionals and non-profit diabetes
advocates.




Note for media:

  • Pooled photo opportunity

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 00:00
If You Feel Trapped In A Broken Healthcare System, This Book Is For You
Author Kory L. Wilson and his family have experienced the benefits of information he shares in Home Remedies: A Guidebook To Breaking Away From Big Pharma ($15.99, paperback, 9781662896668; $6.99, e-book, 9781662896675). For years, I have collected...

15 mai 2024
CloudMD Reports 2023 Results for the Full Year and Fourth Quarter
Full year 2023 revenue of $90.9 million compared to $99.4 million in 2022, and $90.5 million compared to $86.7 million on a normalized basis, excluding one-time COVID mandates.Q4 2023 gross profit margin1 of 39.7% was relatively flat compared to Q3...

15 mai 2024
Fosun International Earns a Spot on "2024 Fortune China ESG Impact List"
On 13 May 2024, Fortune China magazine released the 2024 China ESG Impact List, and Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was included in the list, highlighting its outstanding performance and...

15 mai 2024
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for Presentations at 2024 European Hematology Association Hybrid Congress
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...

15 mai 2024
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

15 mai 2024
Starlight Children's Foundation CEO, Adam Garone, Named Nonprofit Executive of the Year by Los Angeles Business Journal
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

More news about Health...


News published on and distributed by: